The ASX 200 biotech stock has lost 9% of its value since the start of the new year. The post Why is the CSL share price ...

Its long-term returns have been outstanding. Yet eroding fundamentals and today’s prohibitive valuation imply tomorrow’s ...

CSL Limited ( ASX:CSL ) stock is about to trade ex-dividend in 2 days. The ex-dividend date is usually set to be ...

Which of these healthcare giants is a better buy? The post Are Sonic Healthcare or CSL shares a better buy? appeared first on ...

CSL Vifor Thank you for standing by and welcome to the CSL Limited Half Year Financial Results. All participants are in a listen-only mode. There will be a presentation followed by a question-and ...

CSL Limited (ASX:CSL) shareholders are probably feeling a little disappointed, since its shares fell 4.8% to AU$257 in the week after its latest half-year results. Revenues of US$8.5b were in line ...

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Esperion Therapeutics (NASDAQ: ESPR) today announced it has entered into a license and distribution agreement with CSL Seqirus (ASX:CSL) for the exclusive rights to commercialize NEXLETOL ® (bempedoic ...

Learn More The CSL Ltd (ASX: CSL) share price is down 1.6% to $255.51 per share on Monday. The ASX 200 biotech is in the red today because its shares have begun trading ex-dividend. The CSL share ...

Two of those to consider are Sonic Healthcare Ltd (ASX: SHL) and CSL Ltd (ASX: CSL) shares. Both businesses have been on the ASX for many years. CSL is a major vaccine and blood plasma product ...